Key timing considerations: Broader Tmax window (8 to 72 hours) means less precision in predicting peak effects Dual GIP/GLP-1 mechanism may produce a different side effect timing pattern than pure GLP-1 agonists Body aches and muscle pain may peak later than GI symptoms, around 24 to 48 hours post-injection Consider how tirzepatide affects metabolism throughout the weekly cycle The appetite suppression timeline may differ from semaglutide due to the dual mechanism Dose escalation timing: Tirzepatide starts at 2.5mg weekly, escalating to 5mg after 4 weeks
The body responds to consistency, not intensity
Each step exists for a specific reason related to absorption science
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 2021 [Available from: Aggarwal R, Vaduganathan M, Chiu N, Bhatt DL
Most patients regain significant weight within 1 year of stopping without behavioral support (STEP 1 extension data)
Glucagon-like Peptide 1 (GLP-1). Molecular Metabolism, vol